Do you lose muscle on Zepbound or Ozempic?

Yes. Zepbound (tirzepatide) and Ozempic (semaglutide) can lead to some muscle loss during weight reduction, especially without adequate protein intake and resistance training. However, most muscle loss can be minimized with proper nutrition and strength-focused exercise.

How much protein do you need to prevent muscle loss on GLP-1 medications?

Most adults on GLP-1 medications benefit from about 1.2–1.6 grams of protein per kilogram of body weight daily. This higher intake supports lean body mass preservation during weight loss with semaglutide or tirzepatide.

Does strength training help prevent muscle loss on semaglutide or tirzepatide?

Yes. Resistance training is one of the most effective ways to preserve muscle while losing weight on semaglutide or tirzepatide. Even two to three sessions per week can help maintain strength and reduce lean mass loss.

Is muscle loss from GLP-1 medications permanent?

No. Muscle loss during GLP-1 weight loss is not permanent if addressed early. With adequate protein intake and resistance training, most patients can maintain or regain lean body mass over time.

What is the best way to preserve lean body mass on Zepbound or Ozempic?

The most effective approach combines adequate protein intake (about 1.2–1.6 g/kg/day) with regular resistance training. Together, these strategies help preserve lean body mass while maximizing fat loss during treatment.

Do you need a DEXA scan to monitor muscle loss on GLP-1 medications?

No. A DEXA scan is not required for most patients, but it can provide precise measurements of fat and lean mass changes. Many patients can monitor progress with strength, function, and body composition trends instead.

How to Prevent Muscle Loss on Zepbound® & Ozempic® (GLP-1 Agonists): Evidence-Based Strategies

Joshua Silva, MD
2 days ago
5 min read

Medically authored by Joshua Silva, MD | Evidence-Based Weight Loss at Potere Health MD

How do you prevent muscle loss on Zepbound® or Ozempic®?

Muscle loss — or reductions in lean body mass (LBM) — during GLP-1 therapy with semaglutide or tirzepatide is largely preventable. The most effective strategy is combining resistance training 2–3 times per week with adequate daily protein intake (~1.2–1.6 g/kg/day). Strength training provides the mechanical stimulus needed to preserve lean mass during weight loss, while sufficient protein supports muscle protein balance.¹,²

🔗 For a detailed explanation of why GLP-1 medications can affect lean mass and how clinical trials interpret muscle loss, see our full guide: GLP-1 Muscle Loss: Semaglutide, Tirzepatide, and Lean Mass Explained.

Potere Health MD medical infographic illustrating the "Muscle-Preserving Triad" for patients on GLP-1 agonists like Zepbound and Ozempic. The graphic details resistance training frequency (2-3x weekly), daily protein intake targets (1.2-1.6 g/kg), and the use of DEXA scans or strength monitoring to prevent lean body mass reduction during weight loss. — **Evidence-Based Strategies from Potere Health MD:** This framework outlines the synergy between mechanical stimulus (resistance training) and nutritional substrate (adequate protein) to counter sarcopenic obesity during semaglutide or tirzepatide therapy.

What is the best exercise to preserve muscle on semaglutide or tirzepatide?

Resistance training is the most effective exercise for preserving muscle while taking GLP-1 medications. Strength training 2–3 times per week provides the mechanical stimulus needed to maintain lean mass during weight loss. Cardio supports heart health but should not replace strength work.

Recommended Strength Routine for GLP-1 Patients

Perform full-body resistance training 2–3 times per week
Prioritize compound movements (squats, hinges, presses, rows)
Progressively increase weight or repetitions
Avoid excessive cardio that replaces strength sessions
Monitor strength and functional performance, not just scale weight

How much protein should you eat on Mounjaro® or Ozempic® to maintain muscle?

Most patients taking GLP-1 medications should aim for ~1.2–1.6 grams of protein per kilogram of body weight per day (about 0.55–0.75 g per pound).²,³ Higher intake may be appropriate when performing regular resistance training.

These targets are derived from weight-loss and muscle preservation studies during energy restriction.²,³

Practical shortcut (no math):

At least ~100 grams of protein per day as a baseline target, or
25–30 grams of protein per meal, prioritizing breakfast and post-training meals.⁴

These are clinical heuristics to help preserve lean body mass (LBM) during appetite suppression and are not individualized prescriptions.

Safety note: Protein needs vary based on kidney function, age, body size, and medical history and should be individualized with a clinician.

Does protein timing matter for muscle maintenance on GLP-1's?

Total daily protein intake is more important than precise timing for preserving muscle on GLP-1 medications.However, distributing protein evenly across meals may help stimulate muscle protein synthesis.

Research suggests consuming ~20–40 grams of high-quality protein per meal may be more effective for muscle maintenance than frequent low-protein snacks, especially when appetite is reduced.⁴,⁵

Inference note: These recommendations are extrapolated from muscle protein synthesis studies and have not been directly tested in GLP-1–specific trials.

Does cardio cause muscle loss on Zepbound® or Ozempic®?

No — cardiovascular exercise does not inherently cause muscle loss while taking GLP-1 medications. Muscle reduction is more likely if resistance training is absent or overall calorie and protein intake are inadequate.'

Moderate aerobic activity supports heart health and complements strength training. However, excessive endurance exercise without resistance work during rapid weight loss may increase the risk of lean mass reduction.⁶

Preserving muscle requires mechanical loading from resistance training, not aerobic exercise alone.

Is creatine helpful for patients taking semaglutide or tirzepatide?

Creatine is not required while taking GLP-1 medications, but it may help support muscle preservation when combined with resistance training. Although creatine has not been specifically studied during GLP-1 therapy, it is well established to improve strength and training capacity in general populations.⁷

Creatine does not prevent muscle loss on its own and should not replace resistance training or adequate protein intake.

Safety note: Patients with kidney disease or other contraindications should consult a clinician before using creatine.

What are signs of muscle loss while taking GLP-1 medications?

Declining physical strength or exercise tolerance
New difficulty climbing stairs or rising from a chair
Persistent fatigue or weakness despite adequate caloric intake
Reduced grip strength or difficulty carrying objects
Noticeable decrease in muscle tone independent of fat loss

How can you measure muscle loss while on GLP-1 medications?

The most accurate way to assess lean body mass (LBM) changes is with a DEXA scan, which measures fat mass and lean tissue separately. However, most patients can monitor muscle preservation by tracking strength, functional performance, and adequate protein intake.

Home body composition scales use bioelectrical impedance and can estimate lean mass, but accuracy varies based on hydration and recent activity. They are useful for tracking trends over time, not for precise muscle measurement.

When should muscle loss on GLP-1 medications prompt medical evaluation?

Rapid or progressive functional decline
Inability to meet minimum daily protein intake
Persistent nausea or vomiting limiting nutrition
Frequent falls or balance issues
Signs of malnutrition such as severe fatigue or hair loss

Summary: Preventing muscle loss on Zepbound® and Ozempic®

GLP-1 medications do not directly cause muscle wasting. Muscle loss is most likely when resistance training and protein intake are insufficient during weight loss. Preserving lean body mass requires consistent strength training and adequate daily protein throughout treatment with semaglutide or tirzepatide.

Disclaimer

This article is for educational purposes only and is not a substitute for medical advice.

About the Author

Dr. Joshua Silva, MD, is a licensed physician and Medical Director of Potere Health MD. He earned his medical degree from the University of Hawaiʻi John A. Burns School of Medicine and completed residency training in Occupational and Environmental Medicine at the University of Utah, where he also earned a master’s degree in Occupational Health. He later completed a Master of Business Administration with an emphasis in health care administration at Ohio University.

Dr. Silva specializing in evidence-based medical weight management with a focus on GLP-1 and GLP-1/GIP therapies such as semaglutide and tirzepatide. His clinical work emphasizes preserving muscle mass, optimizing protein intake, and integrating resistance training during weight loss to support long-term metabolic health. Dr. Silva provides in-person and virtual care for patients in Salt Lake City, St. George, and Cedar City, Utah.

References (AMA Style)

Lopez P, Taaffe DR, Galvão DA, et al. Resistance training effectiveness on body composition and body weight outcomes in individuals with overweight and obesity across the lifespan: A systematic review and meta-analysis. Obesity Reviews. 2022. https://pubmed.ncbi.nlm.nih.gov/35191588/
Pasiakos SM, Cao JJ, Margolis LM, et al. Effects of high-protein diets on fat-free mass and muscle protein synthesis following weight loss: a randomized controlled trial. FASEB Journal. 2013;27(9):3837-3847. https://pubmed.ncbi.nlm.nih.gov/23739654/
Longland TM, Oikawa SY, Mitchell CJ, Devries MC, Phillips SM. Higher compared with lower dietary protein during an energy deficit combined with intense exercise promotes greater lean mass gain and fat mass loss: a randomized trial. American Journal of Clinical Nutrition. 2016;103(3):738-746. https://pubmed.ncbi.nlm.nih.gov/26817506/
Moore DR, Robinson MJ, Fry JL, et al. Ingested protein dose response of muscle and albumin protein synthesis after resistance exercise in young men. American Journal of Clinical Nutrition. 2009;89(1):161-168. https://pubmed.ncbi.nlm.nih.gov/19056590/
Phillips SM. A brief review of critical processes in exercise-induced muscular hypertrophy. Sports Medicine.2014;44(Suppl 1):S71-S77. https://pubmed.ncbi.nlm.nih.gov/24791918/
Hawley JA. Molecular responses to strength and endurance training: are they incompatible? Applied Physiology, Nutrition, and Metabolism. 2009;34(3):355-361. https://pubmed.ncbi.nlm.nih.gov/19448698/
Kreider RB, Kalman DS, Antonio J, et al. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. Journal of the International Society of Sports Nutrition. 2017;14:18. https://pubmed.ncbi.nlm.nih.gov/28615996/